Primary Ovarian Insufficiency, Polycystic Ovary Syndrome & the CardiOvascular Risk Profile

CompletedOBSERVATIONAL
Enrollment

125

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Cardiovascular Diseases
Interventions
PROCEDURE

cardiovascular screening

cardiovascular screening: serum, urine, ECG, carotid intima media thickness (IMT), cardiac ultrasound

Trial Locations (1)

Unknown

University Medical Center Utrecht, Utrecht

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Amsterdam UMC, location VUmc

OTHER

collaborator

Erasmus Medical Center

OTHER

lead

UMC Utrecht

OTHER

NCT02616510 - Primary Ovarian Insufficiency, Polycystic Ovary Syndrome & the CardiOvascular Risk Profile | Biotech Hunter | Biotech Hunter